Uroalerts Men's Health Weekly

September 23, 2025

Videos

Peer-to-Peer Clinical Conversations

Comparing Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia - Dean Elterman

Dean Elterman

Alan Wein is joined by Dean Elterman to discuss BPH procedure selection based on patient characteristics and preferences.

Criteria for Selecting Sling vs Artificial Sphincter in Incontinence Treatment - Craig Comiter

Craig Comiter

In part four, Alan Wein concludes his discussion with Craig Comiter about male incontinence treatment preferences.

Beyond the Abstracts

Association of Fluid Management During Robotic-Assisted Radical Laparoscopic Prostatectomy with Early Surgical Clinical Outcomes: A Risk Factor for Lymphoceles - Beyond the Abstract

Lessons Learned from Our Preliminary Experience with MiLEP: A Retrospective Analysis of Efficacy and Safety Using Slim and Ultra-Slim Instruments - Beyond the Abstract

Conference Coverage

ASCO 2025: An Open Label Randomized Non-Inferiority Trial Comparing Adjuvant Platinum + Paclitaxel to Platinum + 5-FU After Curative Resection in High-Risk Penile Carcinoma

EAU 2025: Testis Cancer: Micro RNA

EAU 2025: Penile Cancer: HPV status

Articles

Editor Selected Abstracts and Commentaries

Androgen Deficiency

Idiopathic hyperprolactinemia-associated hypogonadism in men presenting with normal testosterone levels.

Male Infertility

Whole-exome sequencing reveals a novel mutation in the SUN5 gene causing acephalic spermatozoa syndrome.

Serum anti-müllerian hormone as a biomarker of functional testicular reserve: a comparative analysis.

Reductive stress and the role of antioxidants in male infertility: a narrative review.

Navigating male infertility through testicular biopsy: outcomes, predictive parameters, and surgical innovation.

Peyronie's Disease

Epigenetic differences in non-plaque tissues of men with Peyronie's disease.

Erectile Dysfunction

Novel low dose rate brachytherapy with focal sparing of neurovascular bundle: Report on the primary outcome from the PRIAPUS trial.

Chronic administration of the hydrogen sulfide prodrug SG1002 partially protects against erectile dysfunction resulting from long-term androgen deprivation.

Efficacy and safety of intracavernosal incobotulinumtoxinA (Xeomin) as add-on therapy to sildenafil for the treatment of erectile dysfunction insufficiently responsive to phosphodiesterase type 5 inhibitors.

Psychological perspectives on male erectile dysfunction: a reappraisal.

BPH - Benign Prostatic Enlargement

Efficacy analysis of 450 nm semiconductor blue laser enucleation of the prostate in treating benign prostatic hyperplasia with urinary retention.

Surgical management of benign prostatic hyperplasia in elderly and frail patients: a narrative review.

First Use of the FloStent™ for Catheter-Dependent Urinary Retention Secondary to BPH: Additional Results from the RAPID I Study.

Urethral complications after holmium laser enucleation of the prostate are more common in patients with smaller prostates.

A scoping review of the role of heritability and environmental exposures in the development and severity of benign prostatic hyperplasia.

Penile & Urethral Cancers

Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical Trial.

The Swedish national guidelines on penile cancer.

Expression profile of small nucleolar RNAs (snoRNAs) in penile cancer.

Sexual and urological reconstruction following penectomy for penile cancer: phalloplasty.

Testicular Cancer

Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphoma.

Role of Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Seminoma: Recommendations from the European Association of Urology Guidelines Panel on Testicular Cancer.

Prostate Cancer

Transperineal 3T MRI-guided and transrectal MRI-ultrasound fusion prostate biopsies: Do lesion location and size impact diagnostic yield?

Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy.

Deep Learning for Automated Measures of SUV and Molecular Tumor Volume in [68Ga]PSMA-11 or [18F]DCFPyL, [18F]FDG, and [177Lu]Lu-PSMA-617 Imaging with Global Threshold Regional Consensus Network.

Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing.

Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer.

Prognostic value of MRI-derived features for biochemical recurrence after curative radiotherapy in prostate cancer.

Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer.

Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry.

Prognostic Significance of RB1 Alterations on Outcomes in Metastatic Prostate Cancer.

PROSTest, a Multigene Liquid Biopsy Signature, Effectively Stratifies Patients With High PSA for Prostate Biopsy.

Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START).

Radiomics Features from Different Prostatic Zones on 18F-PSMA-1007 PET/CT for Predicting Persistent PSA in Prostate Cancer Patients: A Multicenter Study.

Transperineal MRI-US Fusion-Guided Biopsy with Systematic Sampling for Prostate Cancer: Diagnostic Accuracy and Clinical Implications Across PI-RADS.

The Safety of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer: An Individual-Participant Data Meta-Analysis Based on 14 Randomized Clinical Trials.

Training With Local Data Remains Important for Deep Learning MRI Prostate Cancer Detection.

[68Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy.

Real-world data from a single-center cohort of patients with metastatic hormone-sensitive prostate cancer in Spain: analysis of response, progression, and quality of life.

Clinical Implementation of PSMA-PET Guided Tumor Response-Based Boost Adaptation in Online Adaptive Radiotherapy for High-Risk Prostate Cancer.

Association of HOXB13 G84E With Prostate Cancer Among 592,158 Men.

Management of Locally Advanced Prostate Cancer: A Scoping Review of Contemporary Evidence and Emerging Approaches.

The Complex Interplay of Modifiable Risk Factors Affecting Prostate Cancer Disparities in African American Men - Beyond the Abstract

Risk Model for Lymph Node-Positive Prostate Cancer After Radical Prostatectomy - Beyond the Abstract

Comparison of Diagnostic Performance Between Manual Diagnosis Following PROMISE V2 and aPROMISE Utilizing Ga/F‑PSMA PET/CT - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2025 Digital Science Press, LLC